BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 22869753)

  • 1. Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels.
    Margariti A; Winkler B; Karamariti E; Zampetaki A; Tsai TN; Baban D; Ragoussis J; Huang Y; Han JD; Zeng L; Hu Y; Xu Q
    Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13793-8. PubMed ID: 22869753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smooth muscle cells differentiated from reprogrammed embryonic lung fibroblasts through DKK3 signaling are potent for tissue engineering of vascular grafts.
    Karamariti E; Margariti A; Winkler B; Wang X; Hong X; Baban D; Ragoussis J; Huang Y; Han JD; Wong MM; Sag CM; Shah AM; Hu Y; Xu Q
    Circ Res; 2013 May; 112(11):1433-43. PubMed ID: 23529184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced Pluripotent Stem (iPS) Cell Culture Methods and Induction of Differentiation into Endothelial Cells.
    Chatterjee I; Li F; Kohler EE; Rehman J; Malik AB; Wary KK
    Methods Mol Biol; 2016; 1357():311-27. PubMed ID: 25687301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quaking Is a Key Regulator of Endothelial Cell Differentiation, Neovascularization, and Angiogenesis.
    Cochrane A; Kelaini S; Tsifaki M; Bojdo J; Vilà-González M; Drehmer D; Caines R; Magee C; Eleftheriadou M; Hu Y; Grieve D; Stitt AW; Zeng L; Xu Q; Margariti A
    Stem Cells; 2017 Apr; 35(4):952-966. PubMed ID: 28207177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells.
    Hu S; Zhao MT; Jahanbani F; Shao NY; Lee WH; Chen H; Snyder MP; Wu JC
    JCI Insight; 2016 Jun; 1(8):. PubMed ID: 27398408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flk1+ and VE-cadherin+ endothelial cells derived from iPSCs recapitulates vascular development during differentiation and display similar angiogenic potential as ESC-derived cells.
    Kohler EE; Wary KK; Li F; Chatterjee I; Urao N; Toth PT; Ushio-Fukai M; Rehman J; Park C; Malik AB
    PLoS One; 2013; 8(12):e85549. PubMed ID: 24386480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of induced pluripotent stem cell-derived endothelial cells with polycaprolactone/gelatin-based electrospun scaffolds for enhanced therapeutic angiogenesis.
    Tan RP; Chan AHP; Lennartsson K; Miravet MM; Lee BSL; Rnjak-Kovacina J; Clayton ZE; Cooke JP; Ng MKC; Patel S; Wise SG
    Stem Cell Res Ther; 2018 Mar; 9(1):70. PubMed ID: 29562916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
    Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
    J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
    Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
    Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reprogramming fibroblasts into induced pluripotent stem cells with Bmi1.
    Moon JH; Heo JS; Kim JS; Jun EK; Lee JH; Kim A; Kim J; Whang KY; Kang YK; Yeo S; Lim HJ; Han DW; Kim DW; Oh S; Yoon BS; Schöler HR; You S
    Cell Res; 2011 Sep; 21(9):1305-15. PubMed ID: 21709693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of human fibroblasts to functional endothelial cells by defined factors.
    Li J; Huang NF; Zou J; Laurent TJ; Lee JC; Okogbaa J; Cooke JP; Ding S
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1366-75. PubMed ID: 23520160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells.
    Simara P; Tesarova L; Rehakova D; Farkas S; Salingova B; Kutalkova K; Vavreckova E; Matula P; Matula P; Veverkova L; Koutna I
    Stem Cells Dev; 2018 Jan; 27(1):10-22. PubMed ID: 29117787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Versatile In Vivo System to Study Myc in Cell Reprogramming.
    Senís E; Mosteiro L; Grimm D; Abad M
    Methods Mol Biol; 2021; 2318():267-279. PubMed ID: 34019296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-Restricted Stem Cells as Starting Cell Source for Efficient Generation of Pluripotent Stem Cells: An Overview.
    Sundaravadivelu PK; Raina K; Thool M; Ray A; Joshi JM; Kaveeshwar V; Sudhagar S; Lenka N; Thummer RP
    Adv Exp Med Biol; 2022; 1376():151-180. PubMed ID: 34611861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming of ovine adult fibroblasts to pluripotency via drug-inducible expression of defined factors.
    Bao L; He L; Chen J; Wu Z; Liao J; Rao L; Ren J; Li H; Zhu H; Qian L; Gu Y; Dai H; Xu X; Zhou J; Wang W; Cui C; Xiao L
    Cell Res; 2011 Apr; 21(4):600-8. PubMed ID: 21221129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
    Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R
    Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate Standstill Clones Trapped in the Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells.
    Zhang L; Wang Y; Zhang Y; Wang L; Huang H
    Cell Reprogram; 2020 Apr; 22(2):99-105. PubMed ID: 32182120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bio-engineering a tissue flap utilizing a porous scaffold incorporating a human induced pluripotent stem cell-derived endothelial cell capillary network connected to a vascular pedicle.
    Kong AM; Yap KK; Lim SY; Marre D; Pébay A; Gerrand YW; Lees JG; Palmer JA; Morrison WA; Mitchell GM
    Acta Biomater; 2019 Aug; 94():281-294. PubMed ID: 31152943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.
    Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P
    PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.